Thursday, May 24, 2012: 7:00 PM-9:00 PM
The utilization of American Heart Association heart failure guidelines for beta-blocker and angiotensin converting enzyme inhibitor/angiotensin receptor blocker optimization
Ian Haywood, BS, PharmD, Candidate, Laura J. Van Deventer, PharmD, Candidate, MaryAnn E. Birch, PharmD, Emily K. McCoy, PharmD, BCACP, Kristi Kelley, PharmD, BCPS, CDE and Bradley M. Wright, PharmD, BCPS
Auburn University, Harrison School of Pharmacy, Birmingham, AL
Evaluation of screening tools to assess inappropriate medication use in the elderly
Stephanie M. Callinan, BS1 and Timothy Reilly, Pharm.D, BCPS, CGP, FASCP2
1Rutgers, the State University of New Jersey, Piscataway, NJ
2University Medical Center at Princeton, Princeton, NJ
Associations Between Drug Burden Index and Anticholinergic Risk Scale and the Incidence of Adverse Outcomes in Hospitalized Patients
Lisa U. Nguyen, Pharm.D.1, David P. Elliott, Pharm.D.2, Richmond Rebecca, Pharm.D.3, Sankoff R, Pharm.D., Candidate2, Emmett M, Ph.D.3 and Dean S, Ph.D.3
1Charleston Area Medical Center/West Virginia University, Charleston, WV
2West Virginia University, Charleston, WV
3Charleston Area Medical Center, Charleston, WV
Evaluation of prescribed empiric cellulitis therapy at an academic medical center emergency department
Erwin H. Lam, Student, Joseph M. Bissing, Student, Satoru Ito, Student, Asad E. Patanwala, PharmD, BCPS and Kathryn R. Matthias, Pharm.D., BCPS
University of Arizona, Tucson, AZ
Evaluation of combination therapy for Clostridium difficile infection
Jacqueline R. Campbell, Student1, Theresa M. Stehmer, Student1, David E. Nix, PharmD, BCPS2, Donna Wolk, PhD1 and Kathryn R. Matthias, Pharm.D., BCPS1
1University of Arizona, Tucson, AZ
2The University of Arizona College of Pharmacy, Tucson, AZ